X
Access Company Profiles

Get business overview, business operations details specific to this market, products and services, latest developments and more...

Business Email

Select Companies

 

Androgen Deprivation Therapy Companies

This report lists the top Androgen Deprivation Therapy companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Androgen Deprivation Therapy industry.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Androgen Deprivation Therapy Top Companies

  1. Johnson & Johnson

  2. AstraZeneca

  3. Bayer

  4. Astellas Pharma

  5. Tolmar Pharmaceuticals, Inc.

*Disclaimer: Top companies sorted in no particular order

Androgen Deprivation Therapy Market Major Players

Androgen Deprivation Therapy Market Concentration

Androgen Deprivation Therapy  Market Concentration

Androgen Deprivation Therapy Company List

                            • Johnson and Johnson

                            • Astrazeneca

                            • Bayer AG

                            • Astellas Pharma Inc.

                            • AbbVie Inc.

                            • Tolmar Pharmaceuticals, Inc.

                            • Verity Pharmaceuticals Inc.

                            • Foresee Pharmaceuticals Co., Ltd.

                            • Myovant Sciences GmbH

                            • Ferring B.V.

                            • Viatris

                            • Bristol-Myers Squibb Company


                        Specific to Androgen Deprivation Therapy Market
                        Need More Details On Market Players And Competitors?
                        Download PDF

                        Androgen Deprivation Therapy Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)